Target intelligence / Profile preview

Myeloid cell leukemia sequence 1 pseudogene

Molecular classification: Other (Pseudogene)

Overview

The myeloid cell leukemia sequence 1 pseudogene is a non-coding genomic sequence related to the protein-coding gene MCL1 but has no known function, protein product, or role as a therapeutic target. Pseudogenes, by definition, are remnants of formerly functional genes and do not encode active proteins, though some rare pseudogenes can have regulatory roles. In clinical and drug discovery contexts, only the protein-coding MCL1 gene is regarded as a drug target or implicated in disease[4][1][3].

Other names: MCL1 pseudogeneMCL1P

Biological functions

Other (Most pseudogenes, including this one, are not known to be functional; there is no evidence of a protein product or direct functional impact)

Beyond the preview

Go deeper on Myeloid cell leukemia sequence 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myeloid cell leukemia sequence 1 pseudogene.

Explore the full profile